Supporting the mission and goals of National Fentanyl Awareness Day in 2026, including increasing individual and public awareness of the impact of fake or counterfeit fentanyl pills on families and young people.

119th Congress Introduced by Brian Fitzpatrick and 3 co-sponsors

Endorses and promotes National Fentanyl Awareness Day 2026 to educate the public about the dangers of counterfeit fentanyl pills, especially for families and youth.

Submitted in House

Purpose and Intent

HRES 1234 is a House Resolution focused on endorsing and supporting National Fentanyl Awareness Day in 2026.

The resolution aims to increase individual and public awareness about the impact of fake or counterfeit fentanyl pills on families and young people, highlighting safety concerns and public health risks associated with counterfeit drug distribution.

Key Provisions

Endorsement: The measure expresses congressional support for National Fentanyl Awareness Day during 2026.

Awareness and Education: Encourages activities and messaging to educate the public about the dangers of counterfeit fentanyl pills, including how they may look like legitimate medications and the severe health risks they pose.

Public Safety and Health Focus: Emphasizes protecting children, teens, and families from exposure to counterfeit fentanyl and the associated overdose risk.

Community and Stakeholder Engagement: Encourages coordination with federal, state, local governments, schools, health organizations, and community groups to disseminate information and resources.

Non-Binding Nature: As a format typical of House resolutions, the text serves to recognize and promote awareness rather than establish any new statutory program, funding, or regulatory requirements.

Who or What Would Be Affected

General Public: Increased awareness and educational resources about counterfeit fentanyl risks.

Families and Youth: Targeted messaging to prevent accidental ingestion or misuse of counterfeit pills.

Educational and Community Institutions: Potential dissemination of information and participation in awareness activities.

Federal Agencies (informational coordination): The resolution may prompt or encourage collaboration and dissemination of public awareness materials, though it does not create new mandatory duties or funding.

Procedural and Timeline Aspects

Action History:

2026-04-29: Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be determined by the Speaker, in each case for consideration of provisions within their jurisdiction.
2026-04-29: Submitted in the House.

This indicates standard referral to relevant committees with potential consideration of provisions within their jurisdiction; as a resolution, it typically does not authorize new spending or regulatory mandates unless later amended.

Since it is a non-binding concurrent resolution often used to recognize or promote awareness, passage would primarily express congressional support and signal policy priority rather than impose or alter legal requirements.

Notable Details

Sponsors: Acknowledges multiple members as co-sponsors, including Joe Neguse, Brittany Pettersen, Brian Fitzpatrick, and Lori Trahan, reflecting bipartisan engagement.

The text identifies National Fentanyl Awareness Day as the focal event for 2026 and emphasizes counterfeits’ risk to families and youth.

If you would like, I can tailor this summary to highlight potential policy implications, compare to existing public awareness efforts, or extract exact language once the bill's text is publicly available.

Bill